MDT241122P99000
- 0.00
- 0.000.00%
Medtronic Newsroom
Express News | Medtronic PLC : UBS Raises Target Price to $93 From $90
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
Medtronic (MDT) Receives a Buy From RBC Capital
Healing People and Planet: New Impact Report Outlines How Medtronic Is Shaping the Future of Health
SA Charts: These S&P 500 Companies Spent the Largest on Buybacks Last Quarter
Medtronic Is Maintained at Overweight by Wells Fargo
Artificial Intelligence (AI) Reshaping Healthcare Industry With Unimaginable Potential
Stifel Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $87
Express News | Medtronic: Will Initiate Limited Market Release With Existing Standalone Cgm and Inpen Customers Followed by a Broad Commercial Launch
Express News | Medtronic Receives FDA Clearance for New Inpen™ App, Paving the Way for Its Smart Mdi System Launch With Simplera™ Cgm
Medtronic Receives FDA Clearance for New InPen App, Paving the Way for Its Smart MDI System Launch With Simplera CGM
Stifel Nicolaus Sticks to Their Hold Rating for Medtronic (MDT)
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $90 to $105
Baird Maintains Neutral on Medtronic, Lowers Price Target to $93
Express News | Medtronic PLC : Wells Fargo Cuts Target Price to $98 From $106
Medtronic's Mixed Performance and Cautious Outlook Justifies Hold Rating
Medtronic Second Quarter 2025 Earnings: Beats Expectations
Medtronic Analyst Ratings
Analysts Conflicted on These Healthcare Names: Laboratory (LH) and Medtronic (MDT)
Barclays Sticks to Their Buy Rating for Medtronic (MDT)